Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018.

PMID: 35447067
Journal: EMERGING INFECTIOUS DISEASES
Year: 2022
Reference: Emerg Infect Dis. 2022 May;28(5):967-976. doi: 10.3201/eid2805.211958.
Impact factor: 6.883
Publication type: Paper in international publication
Authors: Mir-Cros, Alba, Moreno-Mingorance, Albert, Martin-Gomez, M Teresa, Abad, Raquel, Bloise, Ivan, Campins, Magda, Gonzalez-Praetorius, Alejandro, Gutierrez, M Nieves, Martin-Gonzalez, Hector, Munoz-Almagro, Carmen et al.
DOI: 10.3201/eid2805.211958

Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.

PMID: 34092059
Journal: HAEMATOLOGICA
Year: 2022
Reference: Haematologica. 2022 Apr 1;107(4):887-898. doi: 10.3324/haematol.2021.278990.
Impact factor: 9.941
Publication type: Paper in international publication
Authors: Tovy, Ayala, Rosas, Carina, Gaikwad, Amos S, Medrano, Geraldo, Zhang, Linda, Reyes, Jaime M, Huang, Yung-Hsin, Arakawa, Tastuhiko, Kurtz, Kristen, Conneely, Shannon E et al.
DOI: 10.3324/haematol.2021.278990

Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast percentage AML.

PMID: 35728048
Journal: Blood Advances
Year: 2022
Reference: Blood Adv. 2022 Jun 21. pii: 485649. doi: 10.1182/bloodadvances.2022007334.
Impact factor: 6.799
Publication type: Paper in international publication
Authors: Ades, Lionel, Girshova, Larisa, Doronin, Vadim A, Diez-Campelo, Maria, Valcarcel, David, Kambhampati, Suman, Viniou, Nora-Athina, Woszczyk, Dariusz, De Paz Arias, Raquel, Symeonidis, Argiris et al.
DOI: 10.1182/bloodadvances.2022007334

Phage Therapy of Mycobacterium Infections: Compassionate-use of Phages in Twenty Patients with Drug-Resistant Mycobacterial Disease.

PMID: 35676823
Journal: CLINICAL INFECTIOUS DISEASES
Year: 2022
Reference: Clin Infect Dis. 2022 Jun 9. pii: 6604409. doi: 10.1093/cid/ciac453.
Impact factor: 9.079
Publication type: Paper in international publication
Authors: Davidson, Rebecca M, Cohen, Keira A, Whitney Brown, A, Belessis, Yvonne, Jacobs-Sera, Deborah, Freeman, Krista G, Cristinziano, Madison, Smith, Bailey E, Dedrick, Rebekah M, van Duin, David et al.
DOI: 10.1093/cid/ciac453

Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro-In Vivo Correlation.

PMID: 35159859
Journal: Nanomaterials
Year: 2022
Reference: Nanomaterials (Basel). 2022 Feb 1;12(3). pii: nano12030511. doi: 10.3390/nano12030511.
Impact factor: 5.076
Publication type: Paper in international publication
Authors: Manova, Alena; Bastus, Neus G; Moriones, Oscar H; Kohl, Yvonne; Dusinska, Maria; Runden-Pran, Elise; Puntes, Victor; Nelson, Andrew; Gabelova, Alena; Simon, Peter et al.
DOI: 10.3390/nano12030511

Pharmacotherapeutic interventions for the treatment of bacterial prostatitis.

PMID: 35574695
Journal: EXPERT OPINION ON PHARMACOTHERAPY
Year: 2022
Reference: Expert Opin Pharmacother. 2022 Jun 27:1-11. doi: 10.1080/14656566.2022.2077101.
Impact factor: 3.889
Publication type: Review in international publication
Authors: Marquez-Algaba, Ester, Burgos, Joaquin, Almirante, Benito et al.
DOI: 10.1080/14656566.2022.2077101

Pharmacotherapeutic management of advanced therapy drugs.

PMID: 35379101
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia H
Year: 2022
Reference: Farm Hosp. 2022 Jan 27;46(2):88-95.
Impact factor: 0
Publication type: Paper in international publication
Authors: Poveda-Andres, Jose Luis, Ruiz-Caldes, Maria Jose, Carrera-Soler, Maria Jose, Clopes-Estela, Ana, Flores-Moreno, Sandra, Garcia-Pellicer, Javier, Giraldez-Quiroga, Miriam, Lopez-Briz, Eduardo, Lozano-Blazquez, Ana, Megias-Vericat, Juan Eduardo et al.
DOI: 10.7399/fh.13036

Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study.

PMID: 35205662
Journal: Cancers
Year: 2022
Reference: Cancers (Basel). 2022 Feb 12;14(4). pii: cancers14040915. doi: 10.3390/cancers14040915.
Impact factor: 6.639
Publication type: Paper in international publication
Authors: Poveda, Andres, Lopez-Reig, Raquel, Oaknin, Ana, Redondo, Andres, Rubio, Maria Jesus, Guerra, Eva, Farinas-Madrid, Lorena, Gallego, Alejandro, Rodriguez-Freixinos, Victor, Fernandez-Serra, Antonio et al.
DOI: 10.3390/cancers14040915

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.

PMID: 35338084
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Mar;10(3). pii: jitc-2021-003255. doi: 10.1136/jitc-2021-003255.
Impact factor: 13.751
Publication type: Paper in international publication
Authors: Vidal, Noemi, Garcia-Carbonero, Rocio, Bazan-Peregrino, Miriam, Gil-Martin, Marta, Alvarez, Rafael, Macarulla, Teresa, Riesco-Martinez, Maria C, Verdaguer, Helena, Guillen-Ponce, Carmen, Farrera-Sal, Marti et al.
DOI: 10.1136/jitc-2021-003255

Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas.

PMID: 35815644
Journal: Future Oncology
Year: 2022
Reference: Future Oncol. 2022 Aug;18(24):2639-2649. doi: 10.2217/fon-2022-0196. Epub 2022 Jul 11.
Impact factor: 3.404
Publication type: Review in international publication
Authors: Studeny, Matus, Liu, Meiruo, Hamed, Zohra Oum', Morgensztern, Daniel, Kuboki, Yasutoshi, Gambardella, Valentina, Felip, Enriqueta, Wermke, Martin, Owonikoko, Taofeek K et al.
DOI: 10.2217/fon-2022-0196

Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non-small cell lung cancer.

PMID: 35298959
Journal: LUNG CANCER
Year: 2022
Reference: Lung Cancer. 2022 Apr;166:170-177. doi: 10.1016/j.lungcan.2022.02.010. Epub 2022 Mar 1.
Impact factor: 5.705
Publication type: Paper in international publication
Authors: Santoro, Armando, Su, Wu-Chou, Simonelli, Matteo, Ch Yang, James, Ardizzoni, Andrea, Barlesi, Fabrice, Hyoung Kang, Jin, DiDominick, Sarah, Abdelhady, Ahmed, Chen, Xueying et al.
DOI: 10.1016/j.lungcan.2022.02.010

Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers.

PMID: 35305400
Journal: ESMO Open
Year: 2022
Reference: ESMO Open. 2022 Apr;7(2):100419. doi: 10.1016/j.esmoop.2022.100419. Epub 2022 Mar 16.
Impact factor: 6.54
Publication type: Paper in international publication
Authors: Tabernero, J, Andre, F, Blay, J-Y, Bustillos, A, Fear, S, Ganta, S, Jaeger, D, Maio, M, Mileshkin, L, Melero, I et al.
DOI: 10.1016/j.esmoop.2022.100419

Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO).

PMID: 35257949
Journal: LUNG CANCER
Year: 2022
Reference: Lung Cancer. 2022 Apr;166:107-113. doi: 10.1016/j.lungcan.2022.01.023. Epub 2022 Feb 3.
Impact factor: 5.705
Publication type: Paper in international publication
Authors: Ozguroglu, Mustafa, Rodriguez Abreu, Delvys, Adeniji, Abidemi, Lorence, Robert M, Voccia, Isabelle, Chisamore, Michael J, Riess, Jonathan W, Molinier, Olivier, Madelaine, Jeannick, Kim, Sang-We et al.
DOI: 10.1016/j.lungcan.2022.01.023

Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) +/- anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies.

PMID: 35217575
Journal: Journal for ImmunoTherapy of Cancer
Year: 2022
Reference: J Immunother Cancer. 2022 Feb;10(2). pii: jitc-2021-003776. doi: 10.1136/jitc-2021-003776.
Impact factor: 13.751
Publication type: Paper in international publication
Authors: Carvajal, Richard D, Kyi, Chrisann, Esaki, Taito, Prawira, Amy, Akerley, Wallace, De Braud, Filippo, Hui, Rina, Zhang, Tian, Soo, Ross A, Maur, Michela et al.
DOI: 10.1136/jitc-2021-003776

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on (18)F-FDG PET/CT.

PMID: 35055345
Journal: Journal of Personalized Medicine
Year: 2022
Reference: J Pers Med. 2022 Jan 2;12(1). pii: jpm12010030. doi: 10.3390/jpm12010030.
Impact factor: 4.945
Publication type: Paper in international publication
Authors: Herance, Jose Raul, Simo, Rafael, Velasquez, Mayra Alejandra, Paun, Bruno, Garcia-Leon, Daniel, Aparicio, Carolina, Mares, Roso, Simo-Servat, Olga, Castell-Conesa, Joan, Hernandez, Cristina et al.
DOI: 10.3390/jpm12010030

Pilot hepatitis C micro-elimination strategy in Pakistani migrants in Catalonia through a community intervention.

PMID: 35635535
Journal: LIVER INTERNATIONAL
Year: 2022
Reference: Liver Int. 2022 May 30. doi: 10.1111/liv.15327.
Impact factor: 5.828
Publication type: Paper in international publication
Authors: Martro, Elisa, Ouaarab, Hakima, Saludes, Veronica, Buti, Maria, Trevino, Begona, Roade, Luisa, Egea-Cortes, Laia, Reyes-Urena, Juliana, Not, Anna, Majo, Xavier et al.
DOI: 10.1111/liv.15327

Pilot Study Using Recombinant Antigens r-PROE and r-IGLL1 for the Serodiagnosis of Feather Duvet Lung.

PMID: 35312541
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2022
Reference: Arch Bronconeumol. 2022 Jul;58(7):554-560. doi: 10.1016/j.arbres.2021.02.011. Epub 2021 Mar 4.
Impact factor: 4.872
Publication type: Paper in national publication
Authors: Cruz, Maria Jesus; Millon, Laurence; Villar, Ana; Reboux, Gabriel; Morell, Ferran; Rouzet, Adeline et al.
DOI: 10.1016/j.arbres.2021.02.011

Pineal germinoma in a young adult: A case report.

PMID: 35347869
Journal: Cancer reports (Hoboken, N.J.)
Year: 2022
Reference: Cancer Rep (Hoboken). 2022 Mar 28:e1611. doi: 10.1002/cnr2.1611.
Impact factor: 0
Publication type: Letter or abstract
Authors: Fernandez-Rodriguez, Lissett Jeanette, Maldonado-Pijoan, Xavier et al.
DOI: 10.1002/cnr2.1611

PirePred: An Accurate Online Consensus Tool to Interpret Newborn Screening Related Genetic Variants in Structural Context.

PMID: 35143952
Journal: JOURNAL OF MOLECULAR DIAGNOSTICS
Year: 2022
Reference: J Mol Diagn. 2022 Apr;24(4):406-425. doi: 10.1016/j.jmoldx.2022.01.005. Epub 2022 Feb 7.
Impact factor: 5.568
Publication type: Paper in international publication
Authors: Galano-Frutos, Juan Jose; Garcia-Cebollada, Helena; Lopez, Alfonso; Rosell, Mireia; Cruz, Xavier de la; Fernandez-Recio, Juan; Sancho, Javier et al.
DOI: 10.1016/j.jmoldx.2022.01.005

Placental Tissue Destruction and Insufficiency from COVID-19 Causes Stillbirth and Neonatal Death from Hypoxic-Ischemic Injury: A Study of 68 Cases with SARS-CoV-2 Placentitis from 12 Countries.

PMID: 35142798
Journal: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
Year: 2022
Reference: Arch Pathol Lab Med. 2022 Jun 1;146(6):660-676. doi: 10.5858/arpa.2022-0029-SA.
Impact factor: 5.534
Publication type: Paper in international publication
Authors: Schwartz, David A; Avvad-Portari, Elyzabeth; Babal, Pavel; Baldewijns, Marcella; Blomberg, Marie; Bouachba, Amine; Saad, Ali G; Sand, Anna; Schoenmakers, Sam; Sehn, Jennifer K et al.
DOI: 10.5858/arpa.2022-0029-SA

Planning for the assistance of critically ill patients in a Pandemic Situation: The experience of Vall d'Hebron University Hospital.

PMID: 34872890
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2022
Reference: Enferm Infecc Microbiol Clin (Engl Ed). 2022 Feb;40(2):71-77. doi: 10.1016/j.eimce.2021.11.003. Epub 2021 Nov 26.
Impact factor: 1.731
Publication type: Paper in international publication
Authors: Ferrer, Ricard; Baguena, Marcelino; Balcells, Joan; Baneras, Jordi; Biarnes, Alfons; de Nadal, Miriam; Gracia, Rosa Maria; Martinez, Jesus; Nuvials, Xavier; Riera, Jordi et al.
DOI: 10.1016/j.eimce.2021.11.003

Plasma exosomes in obesity hypoventilation syndrome patients drive lung cancer cell malignant properties: Effect of long-term adherent CPAP treatment.

PMID: 35811031
Journal: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF D
Year: 2022
Reference: Biochim Biophys Acta Mol Basis Dis. 2022 Jul 8;1868(10):166479. doi: 10.1016/j.bbadis.2022.166479.
Impact factor: 5.187
Publication type: Paper in international publication
Authors: Gozal, David, Kheirandish-Gozal, Leila, Khalyfa, Abdelnaby, Masa, Juan F, Qiao, Zhuanhong, Gonzalez, Monica, Marti, Sergi, Khalyfa, Ahamed A et al.
DOI: 10.1016/j.bbadis.2022.166479

Plasma Levels of Mid-Regional Proadrenomedullin Accurately Identify H1N1pdm09 Influenza Virus Patients with Risk of Intensive Care Admission and Mortality in the Emergency Department.

PMID: 35055399
Journal: Journal of Personalized Medicine
Year: 2022
Reference: J Pers Med. 2022 Jan 10;12(1). pii: jpm12010084. doi: 10.3390/jpm12010084.
Impact factor: 4.945
Publication type: Paper in international publication
Authors: Valenzuela-Mendez, Blanca, Valenzuela-Sanchez, Francisco, Rodriguez-Gutierrez, Juan Francisco, Bohollo-de-Austria, Rafael, Estella, Angel, Martinez-Garcia, Pilar, Gonzalez-Garcia, Maria Angela, Rello, Jordi et al.
DOI: 10.3390/jpm12010084

Plasma levels of miRNA-1-3p are associated with subclinical atrial fibrillation in patients with cryptogenic stroke.

PMID: 35067470
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2022
Reference: Rev Esp Cardiol (Engl Ed). 2022 Jan 20. pii: S1885-5857(21)00373-X. doi: 10.1016/j.rec.2021.12.001.
Impact factor: 4.753
Publication type: Paper in national publication
Authors: Ois, Angel, Benito, Begona, Garcia-Elias, Anna, Ble, Mireia, Yanez Bisbe, Laia, Giralt-Steinhauer, Eva, Rodriguez-Campello, Ana, Cladellas Capdevila, Merce, Marti-Almor, Julio, Roquer, Jaume et al.
DOI: 10.1016/j.rec.2021.12.001

Publications